These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36300790)

  • 1. Factors associated with poor outcomes in SLE patients with COVID-19: Data from
    Carvalho JS; Dos Reis Neto ET; Kakehasi AM; Ribeiro SL; Studart SA; Martins FP; Cavalheiro do Espírito Santo R; Ranzolin A; Fernandino DC; Dinis VG; Sato EI; Resende GG; Marinho A; Mariz HA; Sacilotto NC; Ribeiro FM; Shinjo SK; Dias LH; Yazbek MA; Omura F; Rached TH; Gomides APM; Marques CD; Pillegi GC; Mota LM; Pinheiro MM; Monticielo OA; Xavier RM; Ferreira GA;
    Lupus; 2023 Jan; 32(1):42-53. PubMed ID: 36300790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-COVID-19 depression and anxiety in patients with systemic lupus erythematosus.
    Abd El-Khalik DM; Eltohamy M
    Lupus; 2023 Jul; 32(8):974-982. PubMed ID: 37283176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of hospital admissions with active systemic lupus erythematosus disease activity defined by two different disease activity indices: A cohort study.
    Wang CL; Koo M; Hsu CW; Lu MC
    Lupus; 2023 Jun; 32(7):864-872. PubMed ID: 37165549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus.
    Yoshida T; Tsuji H; Onishi A; Takase Y; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Tanaka M; Yoshifuji H; Morinobu A
    Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 35961691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study.
    Ramirez GA; Gerosa M; Bellocchi C; Arroyo-Sánchez D; Asperti C; Argolini LM; Gallina G; Cornalba M; Scotti I; Suardi I; Moroni L; Beretta L; Bozzolo EP; Caporali R; Dagna L
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study.
    Jiang X; Sparks J; Wallace Z; Deng X; Li H; Lu N; Xie D; Wang Y; Zeng C; Lei G; Wei J; Zhang Y
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36889799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of hospital admissions in patients with active systemic lupus erythematosus (SLE) classified according to two different SLE disease activity indices: a prospective cohort study.
    Lu MC; Hsu CW; Koo M; Lai NS
    Clin Exp Rheumatol; 2023 Jul; 41(7):1409-1416. PubMed ID: 36377575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients.
    Jesus D; Rodrigues M; Matos A; Henriques C; Pereira da Silva JA; Inês LS
    Lupus; 2019 Apr; 28(5):607-612. PubMed ID: 30895904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia.
    Espinosa G; Prieto-González S; Llevadot M; Marco-Hernández J; Martínez-Artuña A; Pérez-Isidro A; Rifé E; Cervera R
    Clin Rheumatol; 2021 May; 40(5):2057-2063. PubMed ID: 33677725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Lupus; 2021 Sep; 30(10):1586-1595. PubMed ID: 34192957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data.
    Marques CDL; Ribeiro SLE; Albuquerque CP; de Sousa Studart SA; Ranzolin A; de Andrade NPB; Dantas AT; Mota GD; Resende GG; Marinho AO; Angelieri D; Andrade D; Ribeiro FM; Omura F; Silva NA; Rocha Junior L; Brito DE; Fernandino DC; Yazbek MA; Souza MPG; Ximenes AC; Martins ASS; Castro GRW; Oliveira LC; Freitas ABSB; Kakehasi AM; Gomides APM; Reis Neto ET; Pileggi GS; Ferreira GA; Mota LMH; Xavier RM; de Medeiros Pinheiro M;
    Adv Rheumatol; 2022 Nov; 62(1):45. PubMed ID: 36419163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
    Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
    Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
    Gatto M; Saccon F; Zen M; Regola F; Fredi M; Andreoli L; Tincani A; Urban ML; Emmi G; Ceccarelli F; Conti F; Bortoluzzi A; Govoni M; Tani C; Mosca M; Ubiali T; Gerosa M; Bozzolo E; Canti V; Cardinaletti P; Gabrielli A; Tanti G; Gremese E; De Marchi G; De Vita S; Fasano S; Ciccia F; Pazzola G; Salvarani C; Negrini S; Puppo F; Di Matteo A; De Angelis R; Orsolini G; Rossini M; Faggioli P; Laria A; Piga M; Mathieu A; Scarpato S; Rossi FW; de Paulis A; Brunetta E; Ceribelli A; Selmi C; Prete M; Racanelli V; Vacca A; Bartoloni E; Gerli R; Larosa M; Iaccarino L; Doria A
    Arthritis Rheumatol; 2020 Aug; 72(8):1314-1324. PubMed ID: 32275125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
    Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
    BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus.
    Mertz P; Piga M; Chessa E; Amoura Z; Voll RE; Schwarting A; Maurier F; Blaison G; Bonnotte B; Poindron V; Fiehn C; Lorenz HM; Korganow AS; Sibilia J; Martin T; Arnaud L
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36123013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus.
    Moyon Q; Sterlin D; Miyara M; Anna F; Mathian A; Lhote R; Ghillani-Dalbin P; Breillat P; Mudumba S; de Alba S; Cohen-Aubart F; Haroche J; Pha M; Boutin THD; Chaieb H; Flores PM; Charneau P; Gorochov G; Amoura Z
    Ann Rheum Dis; 2022 Apr; 81(4):575-583. PubMed ID: 34607791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
    Jesus D; Matos A; Henriques C; Zen M; Larosa M; Iaccarino L; Da Silva JAP; Doria A; Inês LS
    Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
    Raiker R; Pakhchanian H; DeYoung C; Gupta L; Kardeş S; Ahmed S; Kavadichanda C
    J Autoimmun; 2021 Dec; 125():102730. PubMed ID: 34649723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
    Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
    Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of SARS-CoV-2 infection on patients with systemic lupus erythematosus in England prior to vaccination: a retrospective observational cohort study.
    Rabe APJ; Loke WJ; Kalyani RN; Tummala R; Stirnadel-Farrant HA; Were J; Winthrop KL
    BMJ Open; 2023 Nov; 13(11):e071072. PubMed ID: 37993165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.